Northumberland company chosen for groundbreaking Covid-19 trials

A Northumberland pharmaceutical company has been chosen to take part in ground breaking clinical trials to counter the effect of Covid-19. Morpeth-based Pharma Nord's Bio-Vitamin D3 will be part of the research designed to look at the effects of vitamin D supplementation on the immune system and protecting against the coronavirus. The supplements will be taken by over 5,000 people for a period of six months as they take part in the Queen Mary University of London ‘Coronavit’ study. Scientists hope that the large-scale trial will help to find out if correcting people’s vitamin D deficiencies over winter can reduce the risk and/or severity of Covid-19 and other acute respiratory infections.